Neptune (NEPT) on Watch with Amarin (AMRN) Halted

July 26, 2012 2:58 PM EDT Send to a Friend
Get Alerts NEPT Hot Sheet
Trade NEPT Now!
Join SI Premium – FREE
Traders are chatting up Neptune Technologies & Bioresources, Inc. (Nasdaq: NEPT) related to the pending FDA approval of Amarin's (Nasdaq: AMRN) AMR101.

AMRN is now halted, with news pending. The decision is expected shortly and most on the Street expected approval. NCE determination is another issue that could be come in August.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Trader Talk

Add Your Comment